Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 23.21% is 42% below its 5-year average of 39.89%, near the high end of its 5-year range (-220.77%–93.75%).
187.84% above its 12-month average of -26.42%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): -220.77%.
GROSS MARGIN
23.21%
GROSS MARGIN AVG TTM
-26.42%
GROSS MARGIN AVG 3Y
26.98%
GROSS MARGIN AVG 5Y
39.89%
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+187.84%
CURRENT VS 3Y AVG
-13.98%
CURRENT VS 5Y AVG
-41.81%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
46.31%
median of 426 covered companies
CURRENT VS SECTOR MEDIAN
-49.89%
vs the sector median at left
bioAffinity Technologies, Inc.
Market Cap
$2.59M
Gross Margin
23.21%
TTM Avg
-26.42%
3Y Avg
26.98%
5Y Avg
39.89%
Market Cap
$2.47M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$2.37M
Gross Margin
63.43%
TTM Avg
61.72%
3Y Avg
62.82%
5Y Avg
60.98%
Market Cap
$2.36M
Gross Margin
-628.02%
TTM Avg
-265.21%
3Y Avg
-2905.33%
5Y Avg
-2576.02%
Market Cap
$3.09M
Gross Margin
92.09%
TTM Avg
93.19%
3Y Avg
96.59%
5Y Avg
97.73%
Market Cap
$3.13M
Gross Margin
0.00%
TTM Avg
-310.04%
3Y Avg
-329.59%
5Y Avg
-274.54%
Market Cap
$1.92M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$3.37M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$3.44M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
25.00%
5Y Avg
50.00%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | $2.59M | 23.21% | -26.42% | 26.98% | 39.89% |
| FibroBiologics, Inc. Common Stock (FBLG)vs › | $2.47M | 0.00% | 0.00% | 0.00% | 0.00% |
| Creative Medical Technology Holdings, Inc. (CELZ)vs › | $2.37M | 63.43% | 61.72% | 62.82% | 60.98% |
| GeoVax Labs, Inc. (GOVX)vs › | $2.36M | -628.02% | -265.21% | -2905.33% | -2576.02% |
| BioRestorative Therapies, Inc. (BRTX)vs › | $3.09M | 92.09% | 93.19% | 96.59% | 97.73% |
| Adagio Medical Holdings, Inc. (ADGM)vs › | $3.13M | 0.00% | -310.04% | -329.59% | -274.54% |
| Autonomix Medical, Inc. (AMIX)vs › | $1.92M | 0.00% | 0.00% | 0.00% | 0.00% |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.37M | 0.00% | 0.00% | 0.00% | 0.00% |
| Aethlon Medical, Inc. (AEMD)vs › | $3.44M | 0.00% | 0.00% | 25.00% | 50.00% |
| IceCure Medical Ltd (ICCM)vs › | $3.47M | 36.10% | 40.19% | 41.87% | 47.28% |
Gross Margin
23.2%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | -220.77% |
| 2026-03-31 | 22.82% |
| 2025-12-31 | 18.91% |
| 2025-09-30 | 27.00% |
| 2025-06-30 | 19.92% |
| 2025-03-31 | 26.21% |
| 2024-12-31 | 22.28% |
| 2024-09-30 | 38.73% |
| 2024-06-30 | 41.29% |
| 2024-03-31 | 34.61% |
| 2023-12-31 | 18.06% |
| 2023-09-30 | 74.97% |
| 2023-06-30 | 93.75% |
| 2023-03-31 | 90.55% |
| 2022-12-31 | 92.54% |
| 2022-09-30 | 87.30% |
| 2022-06-30 | 88.82% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
